| Rank
|
Page title
|
Views
|
Daily average
|
Assessment
|
Importance
|
| 1
|
COVID-19 pandemic
|
216,382
|
6,980
|
GA
|
Top
|
| 2
|
COVID-19
|
163,461
|
5,272
|
C
|
Top
|
| 3
|
Dengue fever
|
160,937
|
5,191
|
FA
|
Top
|
| 4
|
Nipah virus
|
135,978
|
4,386
|
Start
|
Mid
|
| 5
|
Norovirus
|
129,069
|
4,163
|
B
|
Top
|
| 6
|
Epstein–Barr virus
|
126,823
|
4,091
|
B
|
Top
|
| 7
|
Chandipura vesiculovirus
|
102,743
|
3,314
|
Start
|
Low
|
| 8
|
Rabies
|
95,934
|
3,094
|
B
|
Top
|
| 9
|
Shingles
|
95,471
|
3,079
|
GA
|
Top
|
| 10
|
List of epidemics and pandemics
|
93,832
|
3,026
|
List
|
High
|
| 11
|
HIV/AIDS
|
93,306
|
3,009
|
GA
|
Top
|
| 12
|
Rosalind Franklin
|
91,539
|
2,952
|
B
|
High
|
| 13
|
Human papillomavirus infection
|
88,972
|
2,870
|
B
|
Top
|
| 14
|
Smallpox
|
88,465
|
2,853
|
GA
|
Top
|
| 15
|
Respiratory syncytial virus
|
83,945
|
2,707
|
B
|
High
|
| 16
|
Prion
|
78,739
|
2,539
|
GA
|
Top
|
| 17
|
Hand, foot, and mouth disease
|
76,562
|
2,469
|
B
|
High
|
| 18
|
Spanish flu
|
75,722
|
2,442
|
GA
|
Top
|
| 19
|
Molluscum contagiosum
|
71,964
|
2,321
|
B
|
High
|
| 20
|
Canine parvovirus
|
71,904
|
2,319
|
B
|
Top
|
| 21
|
Creutzfeldt–Jakob disease
|
67,565
|
2,179
|
B
|
Top
|
| 22
|
HIV
|
65,615
|
2,116
|
GA
|
Top
|
| 23
|
Influenza A virus
|
64,503
|
2,080
|
B
|
Top
|
| 24
|
HPV vaccine
|
61,541
|
1,985
|
B
|
High
|
| 25
|
Infectious mononucleosis
|
61,371
|
1,979
|
B
|
Top
|
| 26
|
West Nile virus
|
61,050
|
1,969
|
B
|
High
|
| 27
|
Gastroenteritis
|
60,163
|
1,940
|
GA
|
Top
|
| 28
|
Polio
|
60,012
|
1,935
|
B
|
Top
|
| 29
|
Virus
|
56,724
|
1,829
|
FA
|
Top
|
| 30
|
Bell's palsy
|
53,448
|
1,724
|
B
|
Top
|
| 31
|
Hodgkin lymphoma
|
52,358
|
1,688
|
B
|
Top
|
| 32
|
Chickenpox
|
51,895
|
1,674
|
B
|
Top
|
| 33
|
Herpes simplex virus
|
51,631
|
1,665
|
B
|
Top
|
| 34
|
Herpes
|
49,169
|
1,586
|
GA
|
Top
|
| 35
|
Measles
|
47,676
|
1,537
|
B
|
Top
|
| 36
|
COVID-19 pandemic in the United States
|
46,397
|
1,496
|
B
|
Low
|
| 37
|
Rotavirus
|
42,479
|
1,370
|
FA
|
Top
|
| 38
|
Zika virus
|
42,209
|
1,361
|
B
|
Top
|
| 39
|
Cytomegalovirus
|
39,606
|
1,277
|
B
|
Top
|
| 40
|
COVID-19 vaccine
|
38,248
|
1,233
|
B
|
Top
|
| 41
|
SARS-CoV-2
|
37,266
|
1,202
|
B
|
Top
|
| 42
|
Hepatitis B
|
36,855
|
1,188
|
GA
|
Top
|
| 43
|
Canine distemper
|
35,926
|
1,158
|
B
|
Top
|
| 44
|
Rhinovirus
|
32,728
|
1,055
|
C
|
High
|
| 45
|
COVID-19 lockdown in India
|
32,394
|
1,044
|
B
|
Mid
|
| 46
|
Variant Creutzfeldt–Jakob disease
|
32,210
|
1,039
|
B
|
High
|
| 47
|
Hepatitis C
|
31,928
|
1,029
|
GA
|
Top
|
| 48
|
Influenza
|
31,478
|
1,015
|
FA
|
High
|
| 49
|
Yellow fever
|
30,821
|
994
|
B
|
Top
|
| 50
|
Chronic wasting disease
|
28,736
|
926
|
C
|
Top
|
| 51
|
History of HIV/AIDS
|
28,622
|
923
|
B
|
Top
|
| 52
|
Mumps
|
28,563
|
921
|
B
|
Top
|
| 53
|
Ebola
|
28,253
|
911
|
B
|
Top
|
| 54
|
Timeline of the COVID-19 pandemic
|
27,030
|
871
|
List
|
Top
|
| 55
|
Nipah virus infection
|
26,721
|
861
|
C
|
High
|
| 56
|
Bacteriophage
|
26,573
|
857
|
B
|
Top
|
| 57
|
Cold sore
|
26,408
|
851
|
C
|
Top
|
| 58
|
Genital herpes
|
26,248
|
846
|
C
|
High
|
| 59
|
Vaccine
|
26,158
|
843
|
B
|
Top
|
| 60
|
Coronavirus
|
25,713
|
829
|
C
|
High
|
| 61
|
Varicella zoster virus
|
25,435
|
820
|
C
|
High
|
| 62
|
Genital wart
|
24,820
|
800
|
B
|
Top
|
| 63
|
Rubella
|
24,496
|
790
|
B
|
Top
|
| 64
|
Croup
|
24,181
|
780
|
GA
|
Top
|
| 65
|
Common cold
|
22,980
|
741
|
GA
|
Top
|
| 66
|
COVID-19 pandemic in India
|
22,877
|
737
|
B
|
High
|
| 67
|
Foot-and-mouth disease
|
22,546
|
727
|
B
|
High
|
| 68
|
Chikungunya
|
20,785
|
670
|
B
|
High
|
| 69
|
Feline leukemia virus
|
20,779
|
670
|
C
|
High
|
| 70
|
Cervical cancer
|
20,690
|
667
|
B
|
High
|
| 71
|
Oropouche fever
|
20,532
|
662
|
C
|
Low
|
| 72
|
Pandemic
|
20,129
|
649
|
B
|
High
|
| 73
|
Kaposi's sarcoma
|
20,070
|
647
|
C
|
Mid
|
| 74
|
HeLa
|
19,962
|
643
|
C
|
Mid
|
| 75
|
Mpox
|
19,464
|
627
|
C
|
High
|
| 76
|
West Nile fever
|
19,125
|
616
|
C
|
High
|
| 77
|
Nipah virus outbreaks in Kerala
|
18,971
|
611
|
C
|
Low
|
| 78
|
Hepatitis A
|
18,588
|
599
|
B
|
Top
|
| 79
|
Adenoviridae
|
18,305
|
590
|
B
|
High
|
| 80
|
Orthohantavirus
|
18,019
|
581
|
B
|
Top
|
| 81
|
Edward Jenner
|
17,896
|
577
|
B
|
High
|
| 82
|
Roseola
|
17,762
|
572
|
C
|
High
|
| 83
|
Antiviral drug
|
17,561
|
566
|
C
|
Top
|
| 84
|
Influenza A virus subtype H1N1
|
17,546
|
566
|
C
|
Top
|
| 85
|
Coxsackievirus
|
17,395
|
561
|
C
|
High
|
| 86
|
COVID-19 pandemic by country and territory
|
17,344
|
559
|
List
|
Top
|
| 87
|
COVID-19 lab leak theory
|
17,054
|
550
|
B
|
Low
|
| 88
|
SARS
|
16,974
|
547
|
C
|
Top
|
| 89
|
Smallpox vaccine
|
16,538
|
533
|
B
|
Mid
|
| 90
|
COVID-19 lockdowns
|
16,269
|
524
|
B
|
Low
|
| 91
|
Remdesivir
|
15,825
|
510
|
C
|
High
|
| 92
|
Epidemiology of HIV/AIDS
|
15,442
|
498
|
C
|
High
|
| 93
|
2009 swine flu pandemic
|
15,430
|
497
|
GA
|
High
|
| 94
|
Oropouche orthobunyavirus
|
15,328
|
494
|
Start
|
Mid
|
| 95
|
Enterovirus
|
15,292
|
493
|
C
|
High
|
| 96
|
Amantadine
|
15,073
|
486
|
C
|
High
|
| 97
|
Sapovirus
|
15,027
|
484
|
C
|
High
|
| 98
|
List of deaths due to COVID-19
|
14,905
|
480
|
List
|
High
|
| 99
|
Varicella vaccine
|
14,602
|
471
|
B
|
Top
|
| 100
|
Avian influenza
|
14,471
|
466
|
B
|
High
|
| 101
|
Messenger RNA
|
14,175
|
457
|
C
|
High
|
| 102
|
Operation Warp Speed
|
14,072
|
453
|
C
|
High
|
| 103
|
Origin of SARS-CoV-2
|
13,854
|
446
|
C
|
Mid
|
| 104
|
Dengue virus
|
13,770
|
444
|
B
|
Top
|
| 105
|
Feline immunodeficiency virus
|
13,650
|
440
|
C
|
High
|
| 106
|
Influenza B virus
|
13,596
|
438
|
C
|
High
|
| 107
|
Marburg virus
|
13,258
|
427
|
C
|
High
|
| 108
|
COVID-19 pandemic deaths
|
13,024
|
420
|
C
|
Low
|
| 109
|
SARS-CoV-2 Omicron variant
|
12,790
|
412
|
C
|
High
|
| 110
|
Poliovirus
|
12,362
|
398
|
GA
|
High
|
| 111
|
Parvovirus B19
|
12,353
|
398
|
C
|
Mid
|
| 112
|
Retrovirus
|
12,254
|
395
|
C
|
Top
|
| 113
|
HIV/AIDS in the United States
|
12,133
|
391
|
C
|
Low
|
| 114
|
Japanese encephalitis
|
11,986
|
386
|
B
|
High
|
| 115
|
2002–2004 SARS outbreak
|
11,839
|
381
|
B
|
Mid
|
| 116
|
Tick-borne encephalitis
|
11,777
|
379
|
Start
|
Low
|
| 117
|
COVID-19 misinformation
|
11,748
|
378
|
C
|
Low
|
| 118
|
Dengue vaccine
|
11,678
|
376
|
C
|
Low
|
| 119
|
Gardasil
|
11,603
|
374
|
B
|
High
|
| 120
|
Interferon
|
11,555
|
372
|
B
|
Top
|
| 121
|
Influenza A virus subtype H5N1
|
11,432
|
368
|
B
|
Top
|
| 122
|
Human metapneumovirus
|
11,183
|
360
|
C
|
High
|
| 123
|
Herpesviridae
|
11,163
|
360
|
C
|
Top
|
| 124
|
Feline infectious peritonitis
|
11,140
|
359
|
C
|
High
|
| 125
|
List of COVID-19 vaccine authorizations
|
11,073
|
357
|
List
|
Mid
|
| 126
|
Rabies virus
|
11,038
|
356
|
C
|
Top
|
| 127
|
Timeline of the COVID-19 pandemic in the United States (2020)
|
10,672
|
344
|
C
|
Low
|
| 128
|
COVID-19 pandemic in the United Kingdom
|
10,509
|
339
|
C
|
Low
|
| 129
|
COVID-19 vaccination in mainland China
|
10,501
|
338
|
Start
|
Mid
|
| 130
|
Rinderpest
|
10,237
|
330
|
B
|
High
|
| 131
|
Variants of SARS-CoV-2
|
10,036
|
323
|
C
|
Mid
|
| 132
|
Human parainfluenza viruses
|
9,917
|
319
|
C
|
Mid
|
| 133
|
Respiratory syncytial virus vaccine
|
9,885
|
318
|
B
|
Mid
|
| 134
|
Zidovudine
|
9,884
|
318
|
B
|
High
|
| 135
|
Pithovirus
|
9,660
|
311
|
C
|
High
|
| 136
|
Shope papilloma virus
|
9,596
|
309
|
C
|
Mid
|
| 137
|
Merkel-cell carcinoma
|
9,481
|
305
|
C
|
Mid
|
| 138
|
SARS-CoV-1
|
9,419
|
303
|
C
|
High
|
| 139
|
Myxomatosis
|
9,267
|
298
|
GA
|
High
|
| 140
|
Timeline of HIV/AIDS
|
9,248
|
298
|
List
|
Mid
|
| 141
|
Moderna
|
9,165
|
295
|
C
|
Low
|
| 142
|
Vaccination
|
9,011
|
290
|
B
|
Top
|
| 143
|
Western African Ebola epidemic
|
8,901
|
287
|
GA
|
Mid
|
| 144
|
Measles vaccine
|
8,830
|
284
|
C
|
Low
|
| 145
|
Rabies in animals
|
8,744
|
282
|
C
|
High
|
| 146
|
Rotavirus vaccine
|
8,628
|
278
|
C
|
High
|
| 147
|
Tobacco mosaic virus
|
8,581
|
276
|
C
|
High
|
| 148
|
Index case
|
8,515
|
274
|
Start
|
Low
|
| 149
|
Viral hepatitis
|
8,475
|
273
|
C
|
High
|
| 150
|
Influenza vaccine
|
8,383
|
270
|
B
|
Top
|
| 151
|
Bioterrorism
|
8,340
|
269
|
B
|
Low
|
| 152
|
Yellow fever vaccine
|
8,161
|
263
|
C
|
High
|
| 153
|
Virus classification
|
8,081
|
260
|
C
|
Top
|
| 154
|
DNA polymerase
|
7,732
|
249
|
C
|
Top
|
| 155
|
Gain-of-function research
|
7,611
|
245
|
Start
|
High
|
| 156
|
Henipavirus
|
7,603
|
245
|
C
|
High
|
| 157
|
Viral disease
|
7,572
|
244
|
List
|
Top
|
| 158
|
Human herpesvirus 6
|
7,536
|
243
|
C
|
High
|
| 159
|
Subacute sclerosing panencephalitis
|
7,502
|
242
|
C
|
Mid
|
| 160
|
Compartmental models in epidemiology
|
7,448
|
240
|
C
|
Mid
|
| 161
|
Feline calicivirus
|
7,285
|
235
|
C
|
Top
|
| 162
|
Crimean–Congo hemorrhagic fever
|
7,284
|
234
|
C
|
High
|
| 163
|
Molnupiravir
|
7,266
|
234
|
C
|
Mid
|
| 164
|
Vaccine hesitancy
|
7,122
|
229
|
B
|
High
|
| 165
|
Viral hemorrhagic fever
|
7,020
|
226
|
C
|
High
|
| 166
|
Human T-lymphotropic virus 1
|
7,005
|
225
|
C
|
High
|
| 167
|
Swine influenza
|
6,820
|
220
|
B
|
High
|
| 168
|
Virology
|
6,770
|
218
|
B
|
Top
|
| 169
|
Hantavirus pulmonary syndrome
|
6,764
|
218
|
Start
|
High
|
| 170
|
RNA virus
|
6,746
|
217
|
B
|
High
|
| 171
|
Subtypes of HIV
|
6,452
|
208
|
C
|
High
|
| 172
|
Hepatitis C virus
|
6,423
|
207
|
B
|
Top
|
| 173
|
Reverse transcriptase
|
6,389
|
206
|
B
|
Top
|
| 174
|
Viroid
|
6,376
|
205
|
C
|
High
|
| 175
|
RNA interference
|
6,366
|
205
|
FA
|
High
|
| 176
|
Zika fever
|
6,291
|
202
|
B
|
High
|
| 177
|
Host (biology)
|
6,288
|
202
|
GA
|
High
|
| 178
|
Zaire ebolavirus
|
6,282
|
202
|
C
|
Top
|
| 179
|
Polio eradication
|
6,260
|
201
|
B
|
Mid
|
| 180
|
Hepatitis B virus
|
6,181
|
199
|
C
|
Top
|
| 181
|
Human polyomavirus 2
|
6,101
|
196
|
C
|
High
|
| 182
|
Xenophobia and racism related to the COVID-19 pandemic
|
6,077
|
196
|
List
|
Low
|
| 183
|
Impact of the COVID-19 pandemic on cinema
|
5,997
|
193
|
B
|
Low
|
| 184
|
Wuhan Institute of Virology
|
5,996
|
193
|
C
|
Mid
|
| 185
|
Epstein–Barr virus–associated lymphoproliferative diseases
|
5,975
|
192
|
C
|
Mid
|
| 186
|
Lyssavirus
|
5,952
|
192
|
C
|
Mid
|
| 187
|
Orthomyxoviridae
|
5,937
|
191
|
B
|
High
|
| 188
|
COVID-19 pandemic in the Philippines
|
5,862
|
189
|
B
|
Low
|
| 189
|
COVID-19 pandemic in mainland China
|
5,813
|
187
|
C
|
High
|
| 190
|
COVID-19 pandemic in Australia
|
5,802
|
187
|
B
|
Low
|
| 191
|
Hong Kong flu
|
5,704
|
184
|
C
|
Low
|
| 192
|
Marburg virus disease
|
5,675
|
183
|
C
|
High
|
| 193
|
Herpes simplex encephalitis
|
5,664
|
182
|
Start
|
Low
|
| 194
|
COVID-19 pandemic in Europe
|
5,645
|
182
|
C
|
Low
|
| 195
|
Phage therapy
|
5,631
|
181
|
C
|
Top
|
| 196
|
Great Barrington Declaration
|
5,620
|
181
|
B
|
Low
|
| 197
|
Cowpox
|
5,608
|
180
|
C
|
Mid
|
| 198
|
Attenuated vaccine
|
5,559
|
179
|
C
|
High
|
| 199
|
COVID-19 pandemic on cruise ships
|
5,554
|
179
|
B
|
High
|
| 200
|
RNA polymerase
|
5,485
|
176
|
B
|
High
|
| 201
|
Adeno-associated virus
|
5,436
|
175
|
B
|
High
|
| 202
|
Lassa fever
|
5,394
|
174
|
C
|
High
|
| 203
|
Powassan virus
|
5,366
|
173
|
C
|
Mid
|
| 204
|
Hepatitis E
|
5,356
|
172
|
GA
|
High
|
| 205
|
Rhabdoviridae
|
5,350
|
172
|
C
|
High
|
| 206
|
Severe acute respiratory syndrome coronavirus 2
|
5,302
|
171
|
Redirect
|
NA
|
| 207
|
COVID-19 pandemic in New Zealand
|
5,281
|
170
|
C
|
Low
|
| 208
|
Malaysian movement control order
|
5,273
|
170
|
B
|
Low
|
| 209
|
Monkeypox virus
|
5,262
|
169
|
C
|
Mid
|
| 210
|
Viral encephalitis
|
5,250
|
169
|
B
|
High
|
| 211
|
Lentivirus
|
5,236
|
168
|
C
|
Mid
|
| 212
|
COVID-19 pandemic in Germany
|
5,225
|
168
|
C
|
Low
|
| 213
|
Viral pneumonia
|
5,184
|
167
|
Start
|
High
|
| 214
|
Eastern equine encephalitis
|
5,170
|
166
|
C
|
Mid
|
| 215
|
1889–1890 pandemic
|
5,142
|
165
|
C
|
Mid
|
| 216
|
Kaposi's sarcoma-associated herpesvirus
|
5,141
|
165
|
C
|
High
|
| 217
|
Variolation
|
5,102
|
164
|
C
|
High
|
| 218
|
SV40
|
5,053
|
163
|
C
|
Mid
|
| 219
|
Lambda phage
|
5,002
|
161
|
B
|
High
|
| 220
|
Oncovirus
|
4,986
|
160
|
C
|
Top
|
| 221
|
DNA virus
|
4,969
|
160
|
C
|
Top
|
| 222
|
MERS
|
4,962
|
160
|
B
|
High
|
| 223
|
History of COVID-19 vaccine development
|
4,962
|
160
|
C
|
Low
|
| 224
|
Papillomaviridae
|
4,958
|
159
|
B
|
Top
|
| 225
|
African swine fever virus
|
4,957
|
159
|
C
|
High
|
| 226
|
Carcinogenesis
|
4,954
|
159
|
B
|
Mid
|
| 227
|
COVID-19 vaccine misinformation and hesitancy
|
4,953
|
159
|
B
|
Top
|
| 228
|
2001 United Kingdom foot-and-mouth outbreak
|
4,934
|
159
|
C
|
Mid
|
| 229
|
History of smallpox
|
4,915
|
158
|
C
|
Mid
|
| 230
|
Walter Reed
|
4,850
|
156
|
C
|
Low
|
| 231
|
Hershey–Chase experiment
|
4,840
|
156
|
C
|
Mid
|
| 232
|
COVID-19 pandemic in Canada
|
4,833
|
155
|
B
|
Mid
|
| 233
|
List of films impacted by the COVID-19 pandemic
|
4,831
|
155
|
List
|
Mid
|
| 234
|
BK virus
|
4,823
|
155
|
B
|
Low
|
| 235
|
Flavivirus
|
4,797
|
154
|
B
|
High
|
| 236
|
Virulent Newcastle disease
|
4,796
|
154
|
C
|
High
|
| 237
|
COVID-19 pandemic in Victoria
|
4,768
|
153
|
C
|
Low
|
| 238
|
Lady Mary Wortley Montagu
|
4,753
|
153
|
B
|
Low
|
| 239
|
Adenovirus infection
|
4,723
|
152
|
Start
|
Mid
|
| 240
|
HIV vaccine development
|
4,702
|
151
|
C
|
Mid
|
| 241
|
Flat wart
|
4,636
|
149
|
Stub
|
Mid
|
| 242
|
HBsAg
|
4,595
|
148
|
Start
|
High
|
| 243
|
Parvoviridae
|
4,589
|
148
|
B
|
Mid
|
| 244
|
Hendra virus
|
4,573
|
147
|
Start
|
Mid
|
| 245
|
COVID-19 pandemic in Hubei
|
4,571
|
147
|
C
|
Mid
|
| 246
|
2020–2024 H5N1 outbreak
|
4,571
|
147
|
C
|
Low
|
| 247
|
Pandemic H1N1/09 virus
|
4,543
|
146
|
C
|
Mid
|
| 248
|
Travel during the COVID-19 pandemic
|
4,537
|
146
|
C
|
Low
|
| 249
|
2022–2023 mpox outbreak
|
4,533
|
146
|
B
|
Mid
|
| 250
|
Incertae sedis
|
4,525
|
145
|
C
|
Low
|
| 251
|
SARS-CoV-2 Delta variant
|
4,497
|
145
|
C
|
Mid
|
| 252
|
MERS-related coronavirus
|
4,476
|
144
|
B
|
High
|
| 253
|
Rubella virus
|
4,462
|
143
|
C
|
High
|
| 254
|
Economic impact of the COVID-19 pandemic
|
4,438
|
143
|
B
|
Low
|
| 255
|
Influenza pandemic
|
4,434
|
143
|
B
|
Top
|
| 256
|
Timeline of the COVID-19 pandemic in 2019
|
4,411
|
142
|
List
|
High
|
| 257
|
COVID-19 pandemic in Italy
|
4,313
|
139
|
C
|
Mid
|
| 258
|
Capsid
|
4,301
|
138
|
C
|
Top
|
| 259
|
Impact of the COVID-19 pandemic on education
|
4,297
|
138
|
C
|
Low
|
| 260
|
Viral envelope
|
4,273
|
137
|
Start
|
Top
|
| 261
|
Transduction (genetics)
|
4,259
|
137
|
C
|
High
|
| 262
|
Elephant endotheliotropic herpesvirus
|
4,219
|
136
|
GA
|
Mid
|
| 263
|
Human betaherpesvirus 5
|
4,216
|
136
|
C
|
High
|
| 264
|
MOG antibody disease
|
4,212
|
135
|
C
|
Mid
|
| 265
|
COVID-19 pandemic in the Republic of Ireland
|
4,185
|
135
|
C
|
Low
|
| 266
|
Tomato yellow leaf curl virus
|
4,140
|
133
|
C
|
Low
|
| 267
|
Virulence
|
4,126
|
133
|
C
|
High
|
| 268
|
COVID-19 pandemic in California
|
4,123
|
133
|
C
|
Mid
|
| 269
|
Diagnosis of HIV/AIDS
|
4,117
|
132
|
B
|
High
|
| 270
|
Hepatitis D
|
4,111
|
132
|
C
|
Mid
|
| 271
|
Metagenomics
|
4,107
|
132
|
GA
|
High
|
| 272
|
COVID-19 vaccination in India
|
4,095
|
132
|
C
|
Low
|
| 273
|
Arbovirus
|
4,093
|
132
|
C
|
Top
|
| 274
|
Symptoms of COVID-19
|
4,084
|
131
|
C
|
Low
|
| 275
|
Baltimore classification
|
4,017
|
129
|
B
|
Top
|
| 276
|
Face masks during the COVID-19 pandemic
|
4,001
|
129
|
B
|
Low
|
| 277
|
Poxviridae
|
3,985
|
128
|
C
|
High
|
| 278
|
Ebolavirus
|
3,955
|
127
|
C
|
Mid
|
| 279
|
COVID-19 pandemic in North Korea
|
3,922
|
126
|
B
|
Mid
|
| 280
|
COVID-19 vaccination in the United States
|
3,918
|
126
|
Start
|
Low
|
| 281
|
COVID-19 vaccination mandates in the United States
|
3,885
|
125
|
Start
|
Low
|
| 282
|
Escherichia virus T4
|
3,882
|
125
|
Start
|
Mid
|
| 283
|
Viral replication
|
3,778
|
121
|
C
|
Top
|
| 284
|
Lysogenic cycle
|
3,759
|
121
|
C
|
High
|
| 285
|
Echovirus
|
3,758
|
121
|
List
|
Mid
|
| 286
|
Simian immunodeficiency virus
|
3,704
|
119
|
C
|
High
|
| 287
|
Australian bat lyssavirus
|
3,689
|
119
|
C
|
Low
|
| 288
|
Pod People (Invasion of the Body Snatchers)
|
3,687
|
118
|
Start
|
Low
|
| 289
|
Feline coronavirus
|
3,687
|
118
|
C
|
Mid
|
| 290
|
Disease X
|
3,682
|
118
|
GA
|
Low
|
| 291
|
White House Coronavirus Task Force
|
3,657
|
117
|
C
|
Low
|
| 292
|
Non-cellular life
|
3,656
|
117
|
Start
|
Low
|
| 293
|
GS-441524
|
3,639
|
117
|
Start
|
Low
|
| 294
|
Picornavirus
|
3,630
|
117
|
B
|
Mid
|
| 295
|
COVID-19 pandemic in New South Wales
|
3,604
|
116
|
B
|
Low
|
| 296
|
Paramyxoviridae
|
3,540
|
114
|
C
|
High
|
| 297
|
Koplik's spots
|
3,498
|
112
|
C
|
Mid
|
| 298
|
1978 smallpox outbreak in the United Kingdom
|
3,474
|
112
|
B
|
Low
|
| 299
|
Endogenous retrovirus
|
3,474
|
112
|
C
|
Mid
|
| 300
|
Carnivore protoparvovirus 1
|
3,456
|
111
|
Start
|
Mid
|
| 301
|
Strain (biology)
|
3,449
|
111
|
C
|
High
|
| 302
|
COVID-19 pandemic in Japan
|
3,449
|
111
|
C
|
Low
|
| 303
|
Sense (molecular biology)
|
3,437
|
110
|
C
|
High
|
| 304
|
Marek's disease
|
3,435
|
110
|
C
|
Mid
|
| 305
|
History of virology
|
3,419
|
110
|
B
|
Top
|
| 306
|
Measles virus
|
3,401
|
109
|
C
|
Top
|
| 307
|
COVID-19 pandemic in Singapore
|
3,382
|
109
|
B
|
High
|
| 308
|
Hammer-headed bat
|
3,369
|
108
|
GA
|
Low
|
| 309
|
Discrimination against people with HIV/AIDS
|
3,369
|
108
|
C
|
High
|
| 310
|
RNA-dependent RNA polymerase
|
3,348
|
108
|
C
|
Top
|
| 311
|
Coxsackie A virus
|
3,337
|
107
|
Start
|
Mid
|
| 312
|
1977 Russian flu
|
3,335
|
107
|
C
|
Mid
|
| 313
|
Human alphaherpesvirus 1
|
3,318
|
107
|
Start
|
Mid
|
| 314
|
Inclusion bodies
|
3,310
|
106
|
C
|
High
|
| 315
|
Congenital rubella syndrome
|
3,299
|
106
|
Start
|
Mid
|
| 316
|
Ebola virus cases in the United States
|
3,293
|
106
|
C
|
High
|
| 317
|
Intracellular parasite
|
3,274
|
105
|
Start
|
Mid
|
| 318
|
Bluetongue disease
|
3,259
|
105
|
B
|
High
|
| 319
|
List of biosafety level 4 organisms
|
3,259
|
105
|
List
|
Low
|
| 320
|
COVID-19 pandemic in Russia
|
3,250
|
104
|
C
|
Low
|
| 321
|
Giant virus
|
3,244
|
104
|
C
|
High
|
| 322
|
Jonathan Van-Tam
|
3,242
|
104
|
C
|
Low
|
| 323
|
Positive-strand RNA virus
|
3,231
|
104
|
C
|
High
|
| 324
|
COVID-19 pandemic in Maharashtra
|
3,229
|
104
|
C
|
Low
|
| 325
|
Vaccinia
|
3,219
|
103
|
C
|
High
|
| 326
|
Viral evolution
|
3,218
|
103
|
C
|
High
|
| 327
|
Timothy A. Springer
|
3,205
|
103
|
C
|
Low
|
| 328
|
Rabbit hemorrhagic disease
|
3,202
|
103
|
B
|
Mid
|
| 329
|
Kyasanur Forest disease
|
3,201
|
103
|
B
|
Mid
|
| 330
|
Coronavirus spike protein
|
3,163
|
102
|
Start
|
Low
|
| 331
|
Negative-strand RNA virus
|
3,142
|
101
|
B
|
Mid
|
| 332
|
Timeline of the COVID-19 pandemic in Canada
|
3,096
|
99
|
B
|
Mid
|
| 333
|
Rolling circle replication
|
3,090
|
99
|
C
|
Mid
|
| 334
|
Human alphaherpesvirus 2
|
3,050
|
98
|
Start
|
Mid
|
| 335
|
1957–1958 influenza pandemic
|
3,024
|
97
|
C
|
Mid
|
| 336
|
Phage display
|
3,019
|
97
|
C
|
Mid
|
| 337
|
Solid lipid nanoparticle
|
3,011
|
97
|
C
|
Low
|
| 338
|
COVID-19 pandemic in New York City
|
2,992
|
96
|
Start
|
Low
|
| 339
|
Orthopoxvirus
|
2,942
|
94
|
C
|
High
|
| 340
|
Impact of the COVID-19 pandemic on sports
|
2,939
|
94
|
C
|
Mid
|
| 341
|
COVID-19 pandemic on Diamond Princess
|
2,936
|
94
|
Start
|
Low
|
| 342
|
COVID-19 testing
|
2,930
|
94
|
B
|
Low
|
| 343
|
Jamestown Canyon encephalitis
|
2,929
|
94
|
Start
|
Low
|
| 344
|
Face masks during the COVID-19 pandemic in the United States
|
2,929
|
94
|
C
|
Low
|
| 345
|
Virgin cleansing myth
|
2,881
|
92
|
Start
|
Low
|
| 346
|
Eczema herpeticum
|
2,873
|
92
|
Start
|
Low
|
| 347
|
Lytic cycle
|
2,871
|
92
|
C
|
High
|
| 348
|
COVID-19 lockdown in China
|
2,854
|
92
|
C
|
High
|
| 349
|
Natural reservoir
|
2,850
|
91
|
C
|
High
|
| 350
|
Ivermectin during the COVID-19 pandemic
|
2,837
|
91
|
B
|
Low
|
| 351
|
Bat virome
|
2,815
|
90
|
GA
|
High
|
| 352
|
List of unproven methods against COVID-19
|
2,807
|
90
|
List
|
Mid
|
| 353
|
COVID-19 pandemic in Kerala
|
2,792
|
90
|
C
|
Low
|
| 354
|
Orf (disease)
|
2,790
|
90
|
Start
|
Low
|
| 355
|
Rift Valley fever
|
2,772
|
89
|
C
|
High
|
| 356
|
Riboviria
|
2,763
|
89
|
B
|
Top
|
| 357
|
B virus
|
2,752
|
88
|
C
|
Mid
|
| 358
|
COVID-19 pandemic in Malaysia
|
2,746
|
88
|
B
|
High
|
| 359
|
2015–16 Zika virus epidemic
|
2,729
|
88
|
B
|
Mid
|
| 360
|
Impact of the COVID-19 pandemic on the environment
|
2,716
|
87
|
C
|
Low
|
| 361
|
White House COVID-19 outbreak
|
2,678
|
86
|
C
|
Low
|
| 362
|
Innate resistance to HIV
|
2,663
|
85
|
C
|
High
|
| 363
|
Spike protein
|
2,654
|
85
|
Start
|
Low
|
| 364
|
Timeline of human vaccines
|
2,651
|
85
|
List
|
Low
|
| 365
|
Ebola vaccine
|
2,650
|
85
|
C
|
Mid
|
| 366
|
SARS-related coronavirus
|
2,629
|
84
|
C
|
High
|
| 367
|
Coxsackie B virus
|
2,629
|
84
|
C
|
Mid
|
| 368
|
List of Ebola outbreaks
|
2,607
|
84
|
List
|
Low
|
| 369
|
HIV trial in Libya
|
2,577
|
83
|
B
|
Low
|
| 370
|
Spillover infection
|
2,570
|
82
|
Start
|
Mid
|
| 371
|
COVID-19 pandemic in Tamil Nadu
|
2,561
|
82
|
C
|
Low
|
| 372
|
Impact of the COVID-19 pandemic on commercial air transport
|
2,555
|
82
|
C
|
Low
|
| 373
|
Heterophile antibody test
|
2,551
|
82
|
C
|
Low
|
| 374
|
Antibody-dependent enhancement
|
2,537
|
81
|
C
|
High
|
| 375
|
COVID-19 pandemic in Sweden
|
2,532
|
81
|
B
|
Low
|
| 376
|
COVID-19 pandemic in South Africa
|
2,523
|
81
|
B
|
Mid
|
| 377
|
Human coronavirus OC43
|
2,511
|
81
|
C
|
Mid
|
| 378
|
Virus latency
|
2,507
|
80
|
C
|
High
|
| 379
|
Flaviviridae
|
2,503
|
80
|
Start
|
High
|
| 380
|
Bolivian hemorrhagic fever
|
2,500
|
80
|
Start
|
Mid
|
| 381
|
Molluscum contagiosum virus
|
2,490
|
80
|
C
|
Mid
|
| 382
|
Lamivudine
|
2,486
|
80
|
C
|
Mid
|
| 383
|
Influenza A virus subtype H3N2
|
2,481
|
80
|
C
|
High
|
| 384
|
Measles morbillivirus
|
2,479
|
79
|
Redirect
|
NA
|
| 385
|
U.S. state and local government responses to the COVID-19 pandemic
|
2,477
|
79
|
C
|
Mid
|
| 386
|
Vertically transmitted infection
|
2,471
|
79
|
C
|
High
|
| 387
|
Communication of the Trump administration during the COVID-19 pandemic
|
2,461
|
79
|
C
|
Low
|
| 388
|
Structure and genome of HIV
|
2,458
|
79
|
B
|
High
|
| 389
|
Timeline of the COVID-19 pandemic in January 2020
|
2,455
|
79
|
List
|
High
|
| 390
|
Pleomorphism (microbiology)
|
2,448
|
78
|
C
|
High
|
| 391
|
Viral shedding
|
2,440
|
78
|
Start
|
High
|
| 392
|
Primate T-lymphotropic virus
|
2,425
|
78
|
C
|
High
|
| 393
|
Emerging infectious disease
|
2,417
|
77
|
Start
|
Low
|
| 394
|
Transmission of COVID-19
|
2,405
|
77
|
C
|
High
|
| 395
|
Impact of the COVID-19 pandemic on the video game industry
|
2,373
|
76
|
C
|
Low
|
| 396
|
COVID-19 misinformation by the United States
|
2,361
|
76
|
C
|
Low
|
| 397
|
Astrovirus
|
2,342
|
75
|
B
|
Low
|
| 398
|
H5N1 vaccine
|
2,341
|
75
|
C
|
Low
|
| 399
|
PEGylation
|
2,328
|
75
|
C
|
Low
|
| 400
|
2020–21 Singapore circuit breaker measures
|
2,317
|
74
|
C
|
Low
|
| 401
|
Ross River virus
|
2,314
|
74
|
C
|
Mid
|
| 402
|
Plant virus
|
2,304
|
74
|
C
|
Top
|
| 403
|
Superinfection
|
2,284
|
73
|
Stub
|
Mid
|
| 404
|
Hantavirus hemorrhagic fever with renal syndrome
|
2,276
|
73
|
Start
|
High
|
| 405
|
Psittacine beak and feather disease
|
2,272
|
73
|
Start
|
Mid
|
| 406
|
European respirator standards
|
2,262
|
72
|
C
|
Mid
|
| 407
|
Orthornavirae
|
2,256
|
72
|
B
|
High
|
| 408
|
U.S. federal government response to the COVID-19 pandemic
|
2,251
|
72
|
C
|
Mid
|
| 409
|
Reverse-transcriptase inhibitor
|
2,243
|
72
|
C
|
High
|
| 410
|
Caliciviridae
|
2,236
|
72
|
C
|
Mid
|
| 411
|
List of diseases of the honey bee
|
2,227
|
71
|
List
|
High
|
| 412
|
SARS-CoV-2 Alpha variant
|
2,222
|
71
|
C
|
Low
|
| 413
|
COVID-19 pandemic in Greece
|
2,217
|
71
|
C
|
Low
|
| 414
|
Vaccine shedding
|
2,215
|
71
|
Start
|
Mid
|
| 415
|
Mumps virus
|
2,204
|
71
|
B
|
High
|
| 416
|
Deployment of COVID-19 vaccines
|
2,184
|
70
|
C
|
High
|
| 417
|
Filoviridae
|
2,171
|
70
|
Start
|
High
|
| 418
|
Conjugate vaccine
|
2,170
|
70
|
C
|
High
|
| 419
|
Superspreading event
|
2,170
|
70
|
C
|
High
|
| 420
|
Political impact of the COVID-19 pandemic
|
2,146
|
69
|
B
|
Low
|
| 421
|
Alphavirus
|
2,144
|
69
|
B
|
Mid
|
| 422
|
Polyomaviridae
|
2,143
|
69
|
C
|
High
|
| 423
|
COVID-19 pandemic in Pakistan
|
2,139
|
69
|
B
|
Low
|
| 424
|
Ebola virus
|
2,136
|
68
|
Redirect
|
NA
|
| 425
|
Oncolytic virus
|
2,131
|
68
|
B
|
Mid
|
| 426
|
COVID-19 pandemic in France
|
2,129
|
68
|
B
|
Mid
|
| 427
|
Human mortality from H5N1
|
2,089
|
67
|
C
|
High
|
| 428
|
Viral vector vaccine
|
2,087
|
67
|
Start
|
Low
|
| 429
|
Feline viral rhinotracheitis
|
2,078
|
67
|
C
|
Top
|
| 430
|
Chinese government response to COVID-19
|
2,072
|
66
|
B
|
Mid
|
| 431
|
Negri body
|
2,067
|
66
|
Start
|
Mid
|
| 432
|
Timeline of the COVID-19 pandemic in New Zealand (2020)
|
2,053
|
66
|
List
|
Low
|
| 433
|
COVID-19 pandemic in Hong Kong
|
2,050
|
66
|
C
|
Low
|
| 434
|
Mimivirus
|
2,047
|
66
|
C
|
Mid
|
| 435
|
List of virus species
|
2,046
|
66
|
List
|
Top
|
| 436
|
COVID-19 pandemic in South Korea
|
2,042
|
65
|
B
|
Low
|
| 437
|
Global spread of H5N1
|
2,031
|
65
|
B
|
High
|
| 438
|
Human betaherpesvirus 7
|
2,025
|
65
|
C
|
Mid
|
| 439
|
Nanoparticle drug delivery
|
2,025
|
65
|
C
|
Low
|
| 440
|
HA-tag
|
2,023
|
65
|
Start
|
High
|
| 441
|
Bunyavirales
|
1,997
|
64
|
C
|
Mid
|
| 442
|
Richard H. Ebright
|
1,997
|
64
|
Start
|
Mid
|
| 443
|
Lassa mammarenavirus
|
1,994
|
64
|
Start
|
Mid
|
| 444
|
Ovine rinderpest
|
1,984
|
64
|
C
|
Low
|
| 445
|
Flu season
|
1,982
|
63
|
C
|
High
|
| 446
|
Human coronavirus NL63
|
1,980
|
63
|
C
|
Low
|
| 447
|
HIV/AIDS in Russia
|
1,974
|
63
|
Start
|
Low
|
| 448
|
Timeline of the COVID-19 pandemic in March 2020
|
1,958
|
63
|
List
|
High
|
| 449
|
Enterovirus 71
|
1,956
|
63
|
Start
|
High
|
| 450
|
Cervarix
|
1,948
|
62
|
C
|
Mid
|
| 451
|
DNA vaccine
|
1,940
|
62
|
Start
|
Low
|
| 452
|
Lymphocytic choriomeningitis
|
1,908
|
61
|
C
|
Mid
|
| 453
|
Timeline of the COVID-19 pandemic in New Zealand (2021)
|
1,908
|
61
|
List
|
Low
|
| 454
|
HIV/AIDS in the Philippines
|
1,903
|
61
|
Start
|
Low
|
| 455
|
Fowlpox
|
1,897
|
61
|
Start
|
Low
|
| 456
|
British government response to the COVID-19 pandemic
|
1,894
|
61
|
C
|
Low
|
| 457
|
Lumpy skin disease
|
1,893
|
61
|
C
|
Mid
|
| 458
|
White House COVID-19 Response Team
|
1,880
|
60
|
List
|
Low
|
| 459
|
Feed a cold, starve a fever
|
1,871
|
60
|
C
|
Low
|
| 460
|
Banana bunchy top virus
|
1,865
|
60
|
C
|
Mid
|
| 461
|
1793 Philadelphia yellow fever epidemic
|
1,860
|
60
|
C
|
Low
|
| 462
|
History of coronavirus
|
1,845
|
59
|
B
|
Mid
|
| 463
|
Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2020)
|
1,821
|
58
|
List
|
Low
|
| 464
|
Swedish government response to the COVID-19 pandemic
|
1,817
|
58
|
C
|
Low
|
| 465
|
National Institute of Virology
|
1,816
|
58
|
Start
|
High
|
| 466
|
COVID-19 pandemic in North America
|
1,811
|
58
|
C
|
Mid
|
| 467
|
Feline spongiform encephalopathy
|
1,801
|
58
|
Start
|
Low
|
| 468
|
Double-stranded RNA viruses
|
1,798
|
58
|
Start
|
High
|
| 469
|
T7 RNA polymerase
|
1,793
|
57
|
Start
|
Low
|
| 470
|
Viral load
|
1,789
|
57
|
Start
|
Mid
|
| 471
|
Koilocyte
|
1,784
|
57
|
Start
|
Low
|
| 472
|
1998–1999 Malaysia Nipah virus outbreak
|
1,780
|
57
|
C
|
Mid
|
| 473
|
Baculoviridae
|
1,777
|
57
|
C
|
Mid
|
| 474
|
3C-like protease
|
1,766
|
56
|
Start
|
Mid
|
| 475
|
West Nile virus in the United States
|
1,753
|
56
|
C
|
Low
|
| 476
|
Reston virus
|
1,750
|
56
|
C
|
Low
|
| 477
|
HIV superinfection
|
1,749
|
56
|
C
|
Mid
|
| 478
|
Cacao swollen shoot virus
|
1,743
|
56
|
C
|
High
|
| 479
|
2020 coronavirus pandemic in Germany
|
1,742
|
56
|
Redirect
|
NA
|
| 480
|
COVID-19 pandemic in Sri Lanka
|
1,741
|
56
|
B
|
Low
|
| 481
|
COVID-19 pandemic in New York (state)
|
1,740
|
56
|
C
|
Low
|
| 482
|
HIV/AIDS in Thailand
|
1,738
|
56
|
Start
|
Low
|
| 483
|
Equine infectious anemia
|
1,723
|
55
|
Start
|
Mid
|
| 484
|
Tick-borne encephalitis virus
|
1,722
|
55
|
C
|
High
|
| 485
|
COVID-19 pandemic in Michigan
|
1,720
|
55
|
C
|
Low
|
| 486
|
Cucumber mosaic virus
|
1,707
|
55
|
C
|
Mid
|
| 487
|
M13 bacteriophage
|
1,699
|
54
|
Start
|
Mid
|
| 488
|
Obelisk (biology)
|
1,691
|
54
|
Unknown
|
High
|
| 489
|
COVID-19 vaccination in the United Kingdom
|
1,685
|
54
|
C
|
Low
|
| 490
|
COVID-19 pandemic in South Dakota
|
1,670
|
53
|
C
|
Low
|
| 491
|
Hemagglutinin (influenza)
|
1,669
|
53
|
C
|
High
|
| 492
|
Lentiviral vector in gene therapy
|
1,649
|
53
|
C
|
Low
|
| 493
|
COVID-19 pandemic in Bangladesh
|
1,632
|
52
|
Start
|
Mid
|
| 494
|
Neil Ferguson (epidemiologist)
|
1,630
|
52
|
C
|
Mid
|
| 495
|
Bacteriophage MS2
|
1,622
|
52
|
Start
|
Mid
|
| 496
|
Cytopathic effect
|
1,620
|
52
|
C
|
High
|
| 497
|
Arenavirus
|
1,619
|
52
|
C
|
High
|
| 498
|
Pandoravirus
|
1,614
|
52
|
Start
|
High
|
| 499
|
Timeline of the COVID-19 pandemic in New York City
|
1,609
|
51
|
Start
|
Low
|
| 500
|
Black flying fox
|
1,604
|
51
|
C
|
Mid
|
